• 한국공간구조학회지
• /
• 제13권2호
• /
• pp.6-10
• /
• 2013

• 한국진공학회:학술대회논문집
• /
• 한국진공학회 2007년도 제33회 하계학술대회 초록집
• /
• pp.57-57
• /
• 2007

• 월간포장계
• /
• 통권210호
• /
• pp.63-69
• /
• 2010

• 한국우주과학회:학술대회논문집(한국우주과학회보)
• /
• 한국우주과학회 2009년도 한국우주과학회보 제18권1호
• /
• pp.59.2-59.2
• /
• 2009

• 한국자기공명학회:학술대회논문집
• /
• 한국자기공명학회 2002년도 International Symposium on Magnetic Resonance
• /
• pp.61-61
• /
• 2002

• 한국어업기술학회:학술대회논문집
• /
• 한국어업기술학회 1998년도 수산관련공동학술대회발표요지집
• /
• pp.337-337
• /
• 1998

• 한국진공학회:학술대회논문집
• /
• 한국진공학회 2002년도 제23회 학술발표회 초록집
• /
• pp.29-29
• /
• 2002

• 월간포장계
• /
• 통권329호
• /
• pp.80-84
• /
• 2020

• Korean Journal of Radiology
• /
• 제25권1호
• /
• pp.1-5
• /
• 2024

• Molecules and Cells
• /
• 제20권1호
• /
• pp.17-29
• /
• 2005

Therapeutic antibodies represent one of the fastest growing areas of the pharmaceutical industry. There are currently 19 monoclonal antibodies in the market that have been approved by the FDA and over 150 in clinical developments. Driven by innovation and technological developments, therapeutic antibodies are the second largest biopharmaceutical product category after vaccines. Antibodies have been engineered by a variety of methods to suit a particular therapeutic use. This review describes the structural and functional characteristics of antibody and the antibody engineering for the generation and optimization of therapeutic antibodies.